BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamamoto-Furusho JK. Genetic factors associated with the development of inflammatory bowel disease. World J Gastroenterol 2007; 13(42): 5594-5597 [PMID: 17948933 DOI: 10.3748/wjg.v13.i42.5594]
URL: https://www.wjgnet.com/1007-9327/full/v13/i42/5594.htm
Number Citing Articles
1
Masayoshi Onuki, Masaki Watanabe, Narumi Ishihara, Koichiro Suzuki, Kei Takizawa, Masato Hirota, Takahiro Yamada, Aiko Egawa, Osamu Shibahara, Midori Nishii, Michiko Fujihara, Makoto Makishima, Daisuke Takahashi, Yukihiro Furusawa, Hiroki Kakuta, Koji Hase. A partial agonist for retinoid X receptor mitigates experimental colitisInternational Immunology 2019; 31(4): 251 doi: 10.1093/intimm/dxy089
2
Jayantha Arnold, Arvind Sangwaiya, Bharati Bhatkal, Frank Geoghegan, Mark Busbridge. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasisEuropean Journal of Gastroenterology & Hepatology 2009; 21(4): 425 doi: 10.1097/MEG.0b013e32830e2885
3
J.K. Yamamoto-Furusho, G.E. Sánchez-Morales, D. García-Rangel, G. Vargas-Alarcón. Polimorfismos genéticos de interleucina-22 en pacientes con colitis ulcerosaRevista de Gastroenterología de México 2016; 81(2): 86 doi: 10.1016/j.rgmx.2016.02.002
4
Jesús K Yamamoto‐Furusho. Encyclopedia of Life Sciences2009;  doi: 10.1002/9780470015902.a0021483
5
Ayane Mikami, Tasuku Ogita, Fu Namai, Suguru Shigemori, Takashi Sato, Takeshi Shimosato. Oral Administration of Flavonifractor plautii, a Bacteria Increased With Green Tea Consumption, Promotes Recovery From Acute Colitis in Mice via Suppression of IL-17Frontiers in Nutrition 2021; 7 doi: 10.3389/fnut.2020.610946
6
Nallely Bueno-Hernández, Aarón Dominguez-López, Rafael Barreto-Zuñiga, Fausto Sánchez Muñoz, Jesús K. Yamamoto-Furusho. Quantification of low expressed SCD1 gene in colonic mucosa from patients with active ulcerative colitisInflammatory Bowel Diseases 2011; 17(12): E155 doi: 10.1002/ibd.21856
7
Jesús K. Yamamoto-Furusho. Genetic Susceptibility in Inflammatory Bowel DiseaseClinical Reviews in Bone and Mineral Metabolism 2010; 8(3): 149 doi: 10.1007/s12018-009-9068-0
8
Tatiana Sofía Rodríguez-Reyna, Cynthia Martínez-Reyes, Jesús Kazúo Yamamoto-Furusho. Rheumatic manifestations of inflammatory bowel diseaseWorld Journal of Gastroenterology 2009; 15(44): 5517-5524 doi: 10.3748/wjg.15.5517
9
Stephen B. Hanauer. Positioning biologic agents in the treatment of Crohnʼs diseaseInflammatory Bowel Diseases 2009; 15(10): 1570 doi: 10.1002/ibd.20918
10
Phani Krishna Kondamudi, Hemalatha Kovelamudi, Geetha Mathew, Pawan G. Nayak, Mallikarjuna C. Rao, Rekha R. Shenoy. Investigation of Sesamol on Myeloperoxidase and Colon Morphology in Acetic Acid-Induced Inflammatory Bowel Disorder in Albino RatsThe Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/802701
11
Zane Straume, Nikola Krūmiņa, Ilze Elbere, Maija Rozenberga, Laura Blomniece, Renārs Erts, Dace Rudzīte, Jānis Kloviņš, Angelika Krūmiņa. Gut Microbiome Differences Regarding Lifestyle and the History of COVID-19 Disease in Ulcerative Colitis PatientsProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2024; 78(4): 266 doi: 10.2478/prolas-2024-0037
12
Titilayo Omolara Johnson, Augustina Oduje Akinsanmi, Stephen Adakole Ejembi, Olugbenga Eyitayo Adeyemi, Jane-Rose Oche, Grace Inioluwa Johnson, Abayomi Emmanuel Adegboyega. Modern drug discovery for inflammatory bowel disease: The role of computational methodsWorld Journal of Gastroenterology 2023; 29(2): 310-331 doi: 10.3748/wjg.v29.i2.310
13
Mohammad Reza Amini, Zeinab Khademi, Marieh Salavatizadeh, Niloufar Rasaei, Nasser Ebrahimi-Daryani, Ahmad Esmaillzadeh, Azita Hekmatdoost. The association between dietary patterns and disease severity in patients with ulcerative colitisBritish Journal of Nutrition 2024; : 1 doi: 10.1017/S0007114524000187
14
Heidrun Potschka. Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transportAdvanced Drug Delivery Reviews 2012; 64(10): 943 doi: 10.1016/j.addr.2011.12.007
15
J.K. Yamamoto-Furusho. Evaluación del estado nutricional y su asociación con el grado de actividad en pacientes mexicanos con colitis ulcerosa crónica idiopática (CUCI)Revista de Gastroenterología de México 2021; 86(2): 107 doi: 10.1016/j.rgmx.2020.08.004
16
J.K. Yamamoto-Furusho. Evaluation of nutritional status and its association with the grade of activity of ulcerative colitis in Mexican patientsRevista de Gastroenterología de México (English Edition) 2021; 86(2): 107 doi: 10.1016/j.rgmxen.2020.08.003
17
Wolfgang Mönch, Dagmar Breuker, Ute Middermann. Schmerzpsychotherapie2011; : 453 doi: 10.1007/978-3-642-12783-0_25
18
Sarath Sujatha-Bhaskar, Areg Grigorian, Christian de Virgilio. Surgery2020; : 303 doi: 10.1007/978-3-030-05387-1_27
19
May-Bente Bengtson, Camilla Solberg, Geir Aamodt, Jørgen Jahnsen, Bjørn Moum, Jostein Sauar, Morten H. Vatn. Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs diseaseInflammatory Bowel Diseases 2009; 15(12): 1867 doi: 10.1002/ibd.20978
20
J.K. Yamamoto-Furusho, G.E. Sánchez-Morales, D. García-Rangel, G. Vargas-Alarcón. Genetic polymorphisms of interleukin-22 in patients with ulcerative colitisRevista de Gastroenterología de México (English Edition) 2016; 81(2): 86 doi: 10.1016/j.rgmxen.2016.02.006
21
Hai-Xia Shang, An-Qi Wang, Chun-Hui Bao, Huan-Gan Wu, Wei-Feng Chen, Lu-Yi Wu, Rong Ji, Ji-Meng Zhao, Yin Shi. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn’s disease patientsWorld Journal of Gastroenterology 2015; 21(16): 4986-4996 doi: 10.3748/wjg.v21.i16.4986
22
Heidrun Potschka. Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?Epilepsia 2010; 51(8): 1333 doi: 10.1111/j.1528-1167.2010.02585.x
23
Nallely Bueno-Hernández, Fausto Sánchez-Muñoz, Rafael Barreto-Zuñiga, Aarón Dominguez-López, Jesús K. Yamamoto-Furusho. Expression of HNF4γ is downregulated in patients with active ulcerative colitis (UC) compared to UC patients in remission and healthy controlsInflammatory Bowel Diseases 2011; 17(8): E91 doi: 10.1002/ibd.21753
24
Nallely Bueno-Hernández, Martha Núñez-Aldana, Ilse Ascaño-Gutierrez, Jesús K Yamamoto-Furusho. Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaireNutrition Journal 2015; 14(1) doi: 10.1186/s12937-015-0014-3
25
Michael Schultz, Anna Lisa Lindström. Rationale for probiotic treatment strategies in inflammatory bowel diseaseExpert Review of Gastroenterology & Hepatology 2008; 2(3): 337 doi: 10.1586/17474124.2.3.337